Search research articles
Contact Us
Filters
Showing results (81-90 of 193) with videos related to
Page
of 20
Sort By:
Current HIV/AIDS Reports
|
November 8, 2025
Envisioning a Multidisciplinary HBV Cure Research Agenda
Karine Dubé, Ali Ahmed, Chari Cohen, et al.
Annals of Internal Medicine
|
December 12, 2022
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study
Scott Dryden-Peterson, Andy Kim, Arthur Y Kim, et al.
AIDS (London, England)
|
March 28, 2014
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
Benjamin P Linas, Devra M Barter, Jared A Leff, et al.
Journal of Hepatology
|
April 17, 2017
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs
Christine Thöns, Tina Senff, Theresa J Hydes, et al.
Antiviral Therapy
|
October 7, 2015
The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease
Tracey G Simon, Arthur Y Kim, Luisa M Stamm, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
The Journal of Infectious Diseases
|
August 22, 2013
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans
Genevieve Wojcik, Rachel Latanich, Tim Mosbruger, et al.
Contemporary Clinical Trials
|
November 1, 2019
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study
Alain H Litwin, John Jost, Katherine Wagner, et al.
Infection Control and Hospital Epidemiology
|
September 12, 2009
Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers
Kathleen E Corey, Julie C Servoss, Deborah R Casson, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 9, 2017
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD
Meghan E Sise, Elke Backman, Guillermo A Ortiz, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 193) with videos related to
Sort By:
Page
of 20
Current HIV/AIDS Reports
|
November 8, 2025
Envisioning a Multidisciplinary HBV Cure Research Agenda
Karine Dubé, Ali Ahmed, Chari Cohen, et al.
Annals of Internal Medicine
|
December 12, 2022
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study
Scott Dryden-Peterson, Andy Kim, Arthur Y Kim, et al.
AIDS (London, England)
|
March 28, 2014
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
Benjamin P Linas, Devra M Barter, Jared A Leff, et al.
Journal of Hepatology
|
April 17, 2017
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs
Christine Thöns, Tina Senff, Theresa J Hydes, et al.
Antiviral Therapy
|
October 7, 2015
The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease
Tracey G Simon, Arthur Y Kim, Luisa M Stamm, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
The Journal of Infectious Diseases
|
August 22, 2013
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans
Genevieve Wojcik, Rachel Latanich, Tim Mosbruger, et al.
Contemporary Clinical Trials
|
November 1, 2019
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study
Alain H Litwin, John Jost, Katherine Wagner, et al.
Infection Control and Hospital Epidemiology
|
September 12, 2009
Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers
Kathleen E Corey, Julie C Servoss, Deborah R Casson, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 9, 2017
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD
Meghan E Sise, Elke Backman, Guillermo A Ortiz, et al.
Page
of 20